Bahl & Gaynor’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
CCA
CS
EAM
Bahl & Gaynor's OMCL Position: Q3 2019 in Review
Bahl & Gaynor sold out of Omnicell (OMCL) in Q3 2019, closing a stake of 27,122 shares — an estimated $2.33M sold.
Bahl & Gaynor first reported a position in OMCL in Q1 2016 and held it in 14 quarters. The position peaked at $3.43M in Q1 2019. 279 funds tracked by Wall St. Rank hold OMCL as of Q3 2019.
- Bahl & Gaynor reported no remaining Omnicell position as of Q3 2019 after selling out during the quarter.
- Bahl & Gaynor sold 27,122 Omnicell shares in Q3 2019, an estimated $2.33M.
- Bahl & Gaynor first reported a position in Omnicell in Q1 2016 and held it in 14 quarters.
- Bahl & Gaynor's Omnicell position peaked at $3.43M in Q1 2019.
- 279 funds tracked by Wall St. Rank held Omnicell as of Q3 2019.
Based on Bahl & Gaynor's 13F filing for Q3 2019, filed 14 Nov 2019.